Table 3.
Reactogenicity | Obese | Controls | p | ||
---|---|---|---|---|---|
n | % | n | % | ||
Local | |||||
Total | 23/37 | 62.2 | 21/36 | 58.3 | 0.73 |
Male | 12/17 | 70.6 | 7/16 | 43.8 | 0.12 |
Female | 11/20 | 55.0 | 14/20 | 70.0 | 0.33 |
p m/f | p = 0.32 | p = 0.10 | |||
Systemic | |||||
Total | 20/37 | 54.1 | 13/36 | 36.1 | 0.12 |
Male | 10/17 | 58.8 | 7/16 | 43.8 | 0.39 |
Female | 10/20 | 50.0 | 6/20 | 30.0 | 0.20 |
p m/f | p = 0.59 | p = 0.39 |
Incidence of local and systemic reactions to intramuscularly applied TBE vaccine. Frequency of local and systemic reactions as n/group and as percentage for entire group (total), males, and females are indicated. Calculation of p values by general linear model with binomial counts and obesity and gender as factors; comparison by Wald χ2; *p ≤ 0.05.